Verrica Pharmaceuticals Inc (VRCA)
0.9945
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
1.00
+0.01
(+0.55%)
After-Hours: 20:00
Verrica Pharmaceuticals Total Liabilities (Quarterly): 66.98M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 66.98M |
June 30, 2024 | 65.31M |
March 31, 2024 | 64.80M |
December 31, 2023 | 61.83M |
September 30, 2023 | 54.84M |
June 30, 2023 | 6.801M |
March 31, 2023 | 3.793M |
December 31, 2022 | 4.688M |
September 30, 2022 | 4.382M |
June 30, 2022 | 47.10M |
March 31, 2022 | 46.20M |
December 31, 2021 | 47.52M |
September 30, 2021 | 47.90M |
June 30, 2021 | 46.87M |
Date | Value |
---|---|
March 31, 2021 | 46.29M |
December 31, 2020 | 41.17M |
September 30, 2020 | 40.75M |
June 30, 2020 | 38.77M |
March 31, 2020 | 37.83M |
December 31, 2019 | 3.409M |
September 30, 2019 | 4.421M |
June 30, 2019 | 4.405M |
March 31, 2019 | 3.218M |
December 31, 2018 | 2.477M |
September 30, 2018 | 2.451M |
June 30, 2018 | 3.125M |
March 31, 2018 | 1.648M |
December 31, 2017 | 16.12M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.409M
Minimum
Dec 2019
66.98M
Maximum
Sep 2024
38.86M
Average
46.25M
Median
Total Liabilities (Quarterly) Benchmarks
Biomarin Pharmaceutical Inc | 1.438B |
Elite Pharmaceuticals Inc | 40.93M |
Eagle Pharmaceuticals Inc | 152.78M |
TELA Bio Inc | 59.29M |
Terns Pharmaceuticals Inc | 13.76M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 32.93M |
Shareholders Equity (Quarterly) | -34.05M |
Debt to Equity Ratio | -1.272 |
Current Ratio | 1.341 |
Net Debt Paydown Yield | -13.10% |